Mirae Asset Global Etfs Holdings Ltd. Day One Biopharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 38,174 shares of DAWN stock, worth $625,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,174Holding current value
$625,671% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
171Shares Held
73.1MCall Options Held
163KPut Options Held
183K-
Ra Capital Management, L.P. Boston, MA7.87MShares$129 Million1.63% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$105 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$75.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$74.3 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.78MShares$62 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.2B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...